Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: May 21, 2021
Date Accepted: Nov 17, 2021
Date Submitted to PubMed: Aug 26, 2023

The final, peer-reviewed published version of this preprint can be found here:

The Contact Dermatitis Quality of Life Index (CDQL): Survey Development and Content Validity Assessment

Hill MK, Laughter MR, Harmange C, Dellavalle RP, Rundle CW, Dunnick CA

The Contact Dermatitis Quality of Life Index (CDQL): Survey Development and Content Validity Assessment

JMIR Dermatol 2021;4(2):e30620

DOI: 10.2196/30620

PMID: 37632827

PMCID: 10334971

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Development of the CDQL: a comprehensive quality of life measure for patients with contact dermatitis

  • Mary K Hill; 
  • Melissa R Laughter; 
  • Cecile Harmange; 
  • Robert P Dellavalle; 
  • Chandler W Rundle; 
  • Cory A Dunnick

ABSTRACT

Background:

There is limited measurement and reporting of quality of life (QoL) outcomes in contact dermatitis (CD).

Objective:

The purpose of this study is to develop a standardized Contact Dermatitis Quality of Life index (CDQL).

Methods:

A list of 81 topics was compiled from review of QoL measures used previously in CD research. Two rounds of online Delphi surveys were sent to registrants of the 2018 American Contact Dermatitis Society meeting, asking that physicians rank the relevance of topics for measuring QoL in CD using a 4-point scale. Items met consensus for inclusion if at least 78% ranked them as relevant or very relevant and their median score was ≥3.25.

Results:

Thirty-four physicians completed the initial survey and 17 completed the follow-up survey. A total of 22 topics met consensus for inclusion in the CDQL, addressing symptoms, emotions, functions of daily living, social and physical functions, work/school functions, and treatment.

Conclusions:

The study was limited by few open-ended questions in the initial survey, lack of direct patient feedback, and long survey length, which likely contributed to lower survey participation. The CDQL is a comprehensive, CD-specific QoL measure developed on the basis of expert consensus via a modified Delphi process.


 Citation

Please cite as:

Hill MK, Laughter MR, Harmange C, Dellavalle RP, Rundle CW, Dunnick CA

The Contact Dermatitis Quality of Life Index (CDQL): Survey Development and Content Validity Assessment

JMIR Dermatol 2021;4(2):e30620

DOI: 10.2196/30620

PMID: 37632827

PMCID: 10334971

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.